Difficulty: Medium
Average Score: 68%
Practice
A 70-year-old female with osteoporosis is prescribed denosumab. Denosumab works by:
Correct answer
B
Rationale
The correct answer is B: Inhibiting osteoclast activity. Denosumab is a monoclonate antibody that specifically targets and inhibits osteoclasts, the cells responsible for bone resorption. By inhibiting osteoclast activity, denosumab helps to maintain bone density and reduce the risk of fractures in patients with osteoporosis.
Choice A is incorrect because denosumab does not promote osteoblast activity. Choice C is incorrect as denosumab does not affect the absorption of calcium in the intestine. Choice D is incorrect as denosumab does not increase the levels of parathyroid hormone.
Choice A is incorrect because denosumab does not promote osteoblast activity. Choice C is incorrect as denosumab does not affect the absorption of calcium in the intestine. Choice D is incorrect as denosumab does not increase the levels of parathyroid hormone.